Prot #13676-01: A Phase 1 Multidose Study To Evaluate The Safety And Tolerability Of XmAb®13676 In Patients With Cd20-Expressing Hematologic Malignancies

Project: Research project

Project Details

StatusActive
Effective start/end date9/1/179/1/20

Funding

  • Chiltern International, Inc. (Prot #13676-01)
  • Xencor, Inc. (Prot #13676-01)